Vertex Pharmaceuticals Inc. (VRTX)

Index:

Nasdaq 100

$ 491.47
   
  • Change Today:
    $26.45
  • 52 Week High: $513.76
  • 52 Week Low: $374.46
  • Currency: US Dollars
  • Shares Issued: 256.94m
  • Volume: 2,918,342
  • Market Cap: $126,278m
  • RiskGrade: 164

VRTX Overview

Vertex Pharmaceuticals Incorportated in a United States-based drug manufacturer. The company focuses on the research and development of small molecule drugs that are used in the treatment of diseases, including HIV infection & chronic hepatitis C virus.

Listings

Index: S&P 500, Nasdaq 100, Nasdaq Composite
ISIN: US92532F1003

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

VRTX Market Data

Currency US Dollars
Share Price $ 491.47
Change Today $ 26.45
% Change 5.69 %
52 Week High $513.76
52 Week Low $374.46
Volume 2,918,342
Shares Issued 256.94m
Market Cap $126,278m
RiskGrade 164

What The Brokers Say

Strong Buy 9
Buy 11
Neutral 8
Sell 1
Strong Sell 1
Total 30
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 13-Feb-2026

Time Volume / Share Price
15:59 40 @ $491.77
15:59 88 @ $491.77
15:59 163 @ $491.76
15:59 48 @ $491.76
15:59 40 @ $491.66

Top of Page